000			03931cam a2200529 i 4500
001			9781003095989
003			FlBoTFG
005			20240213122831.0
006			m o d
007			cr |||||||||||
008			200615t20212021enka ob 001 0 eng
040			_aOCoLC-P _beng _erda _cOCoLC-P
020			_a9781003095989 _qelectronic book
020			_a1003095984 _qelectronic book
020			_a100021463X _qelectronic book
020			_a9781000214475 _qelectronic book
020			_a1000214478 _qelectronic book
020			_a9781000214550 _qelectronic book
020			_a1000214559 _qelectronic book
020			_a9781000214635 _q(electronic bk.)
020			_z9780367559885 _qhardcover
035			_a(OCoLC)1159660205
035			_a(OCoLC-P)1159660205
050	0	4	_aRA410.9.T9 _bC56 2021
072		7	_aBUS _x070170 _2bisacsh
072		7	_aBUS _x069020 _2bisacsh
072		7	_aBUS _x051000 _2bisacsh
072		7	_aKCC _2bicssc
082	0	0	_a362.1/042509561 _223
100	1		_aÇınaroğlu, Songül, _eauthor.
245	1	0	_aEquity and healthcare reform in developing economies : _bthe case of Turkey / _cSongül Çınaroğlu.
264		1	_aAbingdon, Oxon ; _aNew York, NY : _bRoutledge, _c2021.
264		4	_c©2021
300			_a1 online resource (viii, 165 pages) : _billustrations.
336			_atext _btxt _2rdacontent
337			_acomputer _bn _2rdamedia
338			_aonline resource _bnc _2rdacarrier
490	1		_aRoutledge international studies in health economics
520			_a"Ensuring equity in healthcare is the main concern of health policy makers in order to provide a sustainable health system. This concern is more prominent in developing countries due to the scarcity of resources. This book provides a comprehensive analysis and discussion on the distributive pattern of out-of-pocket pharmaceutical expenditures under the health reforms in Turkey and makes comparisons with pharmerging countries. Turkey's health reforms began in 2003 to address shortcomings related to financial protection and to improve health outcomes and the quality of healthcare services. The primary motivation was to ensure equity in the distribution of health resources, and this transformation process led to profound changes in how these resources were used, and in health financing in general. However, there is a lack of knowledge regarding the long-term effect of health reforms on the distribution patterns of health expenditures and health service use. This book offers a thorough equity analysis of the health financing system, affected by this health transformation program. Index and curve approaches are used in the equity analysis of pharmaceutical expenditures. The book examines the long-term effects of health system regulations on the health spending characteristics of households and improves the current understanding of equity in this context. It includes extensive international comparisons of healthcare services across a range of developing countries and highlights the significance of ensuring equity for emerging economies. The author explores the existing evidence as well as future research directions and provides policy and planning advice for health policy makers to contribute to establishing a more equal health system design. Additionally, the book will be of interest to scholars and professionals in the fields of health economics, public health management and health financing"-- _cProvided by publisher.
588			_aOCLC-licensed vendor bibliographic record.
650		0	_aMedical care, Cost of _zTurkey.
650		0	_aPublic health _zTurkey.
650		7	_aBUSINESS & ECONOMICS / International / Economics _2bisacsh
650		7	_aBUSINESS & ECONOMICS / Public Finance _2bisacsh
856	4	0	_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9781003095989
856	4	2	_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999			_c5789 _d5789